Detalhe da pesquisa
1.
Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Circulation
; 144(22): 1738-1746, 2021 11 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34649459
2.
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
N Engl J Med
; 380(20): 1906-1917, 2019 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31091372
3.
Dabigatran or Aspirin in East Asian Patients With Embolic Stroke of Undetermined Source: RE-SPECT ESUS Subgroup Analysis.
Stroke
; 52(3): 1069-1073, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33588594
4.
Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
Stroke
; 51(6): 1758-1765, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32404035
5.
Dabigatran vs. Aspirin for Secondary Prevention After Embolic Stroke of Undetermined Sourceã- Japanese Subanalysis of the RE-SPECT ESUS Randomized Controlled Trial.
Circ J
; 84(12): 2286-2295, 2020 11 25.
Artigo
Inglês
| MEDLINE | ID: mdl-33132228
6.
Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial.
J Am Heart Assoc
; 11(11): e023545, 2022 06 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35656979
7.
Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial.
Eur J Heart Fail
; 23(5): 826-834, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33609072